Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic therapies that transform patients' lives using the company's industry leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy.
Location: United States, California, Brisbane
Member count: 201-500
Phone: +1 510-970-6000
Founded date: 1995
Investors 3
Mentions in press and media 12
| Date | Title | Description | Category | Author | Source |
| 08.03.2021 | Editas, In... | BRAZIL - 2021/02/18: In this p... | - | - | forbes.com... |
| 10.05.2018 | Should You... | *Updated reference to Pairwise... | - | - | agfunderne... |
| 30.10.2017 | Gene editi... | In its recent report, titled G... | - | - | medcitynew... |
| 10.05.2017 | Pfizer and... | In return for global commercia... | - | - | medcitynew... |
| 25.10.2016 | CRISPR ide... | Whether or not CRISPR/Cas9 gen... | - | - | statnews.c... |
| 18.07.2016 | Do CRISPR ... | WASHINGTON — At scientific mee... | - | - | statnews.c... |
| 09.06.2016 | CRISPR/Cas... | As you might expect given the ... | - | - | medcitynew... |
| 11.08.2015 | CRISPR: Ed... | But that’s already turned quic... | - | - | medcitynew... |
| - | Gene editi... | The field of gene editing is m... | - | - | medcitynew... |
| - | CRISPR: Ed... | CRISPR/Cas9 gene editing has z... | - | - | medcitynew... |
Show more